Heart Failure Management

Patients with heart failure account for about 1 million hospital admissions annually, and another 2 million patients have heart failure as a secondary diagnosis. Many of these patients are readmitted within 90 days for recurrent decompensation.

Denson’s Milrinone Heart Failure Program utilizes the positive effects of inotrope (Milrinone) continuous infusion therapy, along with physician ordered diuretics, beta-blockers, and heart-healthy dietary changes to help prevent hospital re-admissions due to exacerbation.

Denson’s Heart Failure Prevention Program has been developed to optimize physician (PQRS) data through minimized acute re-admissions & health promotion.

Denson Heart Failure Clinical Pathway:

Daily case manager calls to obtain weight & vitals data collection
Intensive health coaching & self-monitoring techniques taught with each visit
Tele-monitoring services available in conjunction with care
Nursing visits a minimum of once a week for in-person assessment
Frequent pharmacy communication to ensure precise infusion protocols
PICC line/CVC care, along with lab draws & lab data benchmarks monitored
Holistic nursing care, with PT, OT, ST as needed/ordered by physician

Denson Home Health, Inc. does not discriminate based on race, color, religion, sex (including gender identity, sexual orientation, and pregnancy), national origin, age, disability or genetic information.

CONTACT US:

201 Flint Ridge Rd, Ste 200
Webster, TX 77598
Phone: (281) 990 – 7000
Fax: (281) 990 – 7672